AQR Arbitrage’s Avadel Pharmaceuticals AVDL Stock Holding History

AQR Arbitrage’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-110,396	Closed	-$2.38M	–	561
2025 Q4	$2.38M	Buy	+110,396	New	+$2.14M	0.05%	268
2015 Q2	–	Sell	-83,300	Closed	-$1.5M	–	417
2015 Q1	$1.5M	Buy	+83,300	New	+$1.3M	0.02%	263

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AQR Arbitrage's AVDL Position: Q1 2026 in Review

AQR Arbitrage sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 110,396 shares — an estimated $2.38M sold.

AQR Arbitrage first reported a position in AVDL in Q1 2015 and held it in 2 quarters. The position peaked at $2.38M in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

AQR Arbitrage reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
AQR Arbitrage sold 110,396 Avadel Pharmaceuticals shares in Q1 2026, an estimated $2.38M.
AQR Arbitrage first reported a position in Avadel Pharmaceuticals in Q1 2015 and held it in 2 quarters.
AQR Arbitrage's Avadel Pharmaceuticals position peaked at $2.38M in Q4 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on AQR Arbitrage's 13F filing for Q1 2026, filed 15 May 2026.